salicylic acid has been researched along with clobetasol in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 13 (65.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akarsu, S; Aktan, S; Ilknur, T; Ozkan, S | 1 |
| Mannino, G; McCaughey, C; Vanness, E | 1 |
| Agarwal, S; Kansal, NK | 1 |
| Koo, J | 1 |
| Feldman, SR; Housman, TS | 1 |
| Hohle, R; Lucke, T; Naineni, KK | 1 |
| Carboni, I; Chimenti, S; Esposito, M; Mazzotta, A; Schipani, C | 1 |
| Aubert, J; Fogel, P; Lui, H; Lynde, C; Poulin, Y; Reiniche, P; Shapiro, J; Soto, P; Villemagne, H; Voegel, JJ | 1 |
| Caveney, SW; Colón, LE; Cook-Bolden, FE; Gottschalk, RW; Hudson, CP; Preston, N; Sofen, H | 1 |
| Barber, K; Berg, M; Kerrouche, N; Lynde, C; Papp, K; Poulin, Y; Prinz, JC; Rives, VP | 1 |
| Kamangar, F; Koo, JY; Nguyen, TV; Wong, JW | 1 |
| Caveney, SW; Gottschalk, RW; Menter, MA | 1 |
| Cleaver, N; Gildenberg, S; Ramirez, J | 1 |
| Camilleri, MJ; Chaudhry, HM; Tolkachjov, SN; Torgerson, RR | 1 |
| Cossu, M; Gavini, E; Giunchedi, P; Langasco, R; Özer, Ö; Rassu, G; Roldo, M; Tanrıverdi, ST | 1 |
| Borgia, F; Cannavò, SP; Giuffrida, R | 1 |
| Culpepper, KS; Hendricks, A; Maarouf, M; Shi, VY | 1 |
| Orlando, G; Piaserico, S; Salmaso, R | 1 |
| Cantwell, HM; Imhof, RL; Proffer, SL; Tolkachjov, SN; Torgerson, RR; Wieland, CN | 1 |
| Kircik, L; Ozyurekoglu, E | 1 |
2 review(s) available for salicylic acid and clobetasol
| Article | Year |
|---|---|
Vitamin D and scalp psoriasis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Calcitriol; Clobetasol; Drug Administration Schedule; Drug Therapy, Combination; Gels; Glucocorticoids; Humans; Ointments; Psoriasis; Scalp; Treatment Outcome | 2002 |
Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasis.
Topics: Administration, Cutaneous; Betamethasone; Calcitriol; Clobetasol; Drug Combinations; Glucocorticoids; Humans; Psoriasis; Quality of Life; Randomized Controlled Trials as Topic; Scalp; Severity of Illness Index; Treatment Outcome | 2012 |
4 trial(s) available for salicylic acid and clobetasol
| Article | Year |
|---|---|
Comparison of the effects of pulsed dye laser, pulsed dye laser + salicylic acid, and clobetasole propionate + salicylic acid on psoriatic plaques.
Topics: Adult; Aged; Clobetasol; Combined Modality Therapy; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Keratolytic Agents; Low-Level Light Therapy; Male; Middle Aged; Prospective Studies; Psoriasis; Salicylic Acid; Treatment Outcome | 2006 |
Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Chemistry, Pharmaceutical; Clobetasol; Female; Humans; Male; Middle Aged; Psoriasis; Scalp; Severity of Illness Index; Treatment Outcome | 2007 |
Gene expression profiling in psoriatic scalp hair follicles: clobetasol propionate shampoo 0.05% normalizes psoriasis disease markers.
Topics: Adult; Biomarkers; Clobetasol; Dermatitis; Drug Resistance; Gene Expression; Gene Expression Profiling; Glucocorticoids; Hair Follicle; Hair Preparations; Humans; Psoriasis; Scalp; Severity of Illness Index | 2010 |
Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Clobetasol; Cushing Syndrome; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Psoriasis; Quality of Life; Scalp; Treatment Outcome | 2011 |
14 other study(ies) available for salicylic acid and clobetasol
| Article | Year |
|---|---|
A case of pityriasis amiantacea with rapid response to treatment.
Topics: Anti-Bacterial Agents; Cephalexin; Clobetasol; Diagnosis, Differential; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Mineral Oil; Pityriasis; Salicylic Acid; Scalp | 2014 |
An itchy, scaly plaque on the scalp.
Topics: Child; Clobetasol; Female; Glucocorticoids; Humans; Keratolytic Agents; Pityriasis; Salicylic Acid; Scalp Dermatoses | 2015 |
Patients' vehicle preference for corticosteroid treatments of scalp psoriasis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Clobetasol; Glucocorticoids; Humans; Patient Acceptance of Health Care; Patient Satisfaction; Pharmaceutical Vehicles; Psoriasis; Scalp | 2003 |
Disseminated superficial actinic porokeratosis of the scalp.
Topics: Aged; Biopsy; Clobetasol; Dermatologic Agents; Glucocorticoids; Humans; Male; Nicotinic Acids; Porokeratosis; Scalp; Treatment Failure | 2007 |
Cost-effectiveness evaluation of clobetasol propionate shampoo (CPS) maintenance in patients with moderate scalp psoriasis: a Pan-European analysis.
Topics: Anti-Inflammatory Agents; Clobetasol; Cost-Benefit Analysis; Europe; Hair Preparations; Humans; Psoriasis; Scalp | 2012 |
Excimer laser therapy for hairline psoriasis: a useful addition to the scalp psoriasis treatment algorithm.
Topics: Aged; Algorithms; Clobetasol; Combined Modality Therapy; Female; Follow-Up Studies; Glucocorticoids; Humans; Lasers, Excimer; Psoriasis; Quality of Life; Scalp; Treatment Outcome | 2012 |
Cutaneous lupus erythematosus in a patient undergoing intravitreal bevacizumab injections: case report and review of the literature.
Topics: Administration, Topical; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid Diseases; Clobetasol; Female; Humans; Injections; Keratosis; Lupus Erythematosus, Cutaneous; Middle Aged; Off-Label Use; Scalp; Skin; Vitreous Body | 2013 |
Frontal fibrosing alopecia among men: A clinicopathologic study of 7 cases.
Topics: Adult; Aged; Alopecia; Anti-Inflammatory Agents; Cheek; Cicatrix; Clobetasol; Dermatologic Agents; Eyebrows; Forehead; Humans; Hydroxychloroquine; Lichen Planus; Male; Middle Aged; Retrospective Studies; Scalp; Tacrolimus | 2017 |
Prolonged skin retention of clobetasol propionate by bio-based microemulsions: a potential tool for scalp psoriasis treatment.
Topics: Administration, Cutaneous; Animals; Biocompatible Materials; Chemistry, Pharmaceutical; Clobetasol; Emulsions; Epidermis; Excipients; Particle Size; Permeability; Psoriasis; Scalp; Skin; Skin Absorption; Swine | 2018 |
Two cases of erosive pustular dermatosis of the scalp occurring after topical 3.75% imiquimod for actinic keratoses.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Clobetasol; Dermatologic Agents; Drug Eruptions; Humans; Imiquimod; Keratosis, Actinic; Male; Scalp; Scalp Dermatoses; Treatment Outcome | 2019 |
Multiple eruptive cutaneous horns on the scalp.
Topics: Administration, Topical; Clobetasol; Desmoglein 3; Exanthema; Female; Fluorescent Antibody Technique; Glucocorticoids; Humans; Injections, Intralesional; Keratosis; Middle Aged; Pemphigus; Scalp; Skin Diseases; Treatment Outcome; Triamcinolone | 2019 |
A Case of Secondary Osteoma Cutis Associated with Lichen Planopilaris.
Topics: Alopecia; Bone Diseases, Metabolic; Clobetasol; Female; Glucocorticoids; Humans; Hydroxychloroquine; Lichen Planus; Middle Aged; Ossification, Heterotopic; Scalp; Scalp Dermatoses; Skin Diseases, Genetic; Treatment Outcome | 2019 |
Lichen planopilaris in men: a retrospective clinicopathologic study of 19 patients.
Topics: Alopecia; Clobetasol; Female; Humans; Lichen Planus; Male; Retrospective Studies; Scalp | 2021 |
An Open-Label Pilot Study to Investigate Safety and Efficacy of Fixed Combination Tazarotene 0.045% and Halobetasol Propionate 0.01% Lotion for the Treatment of Scalp Psoriasis.
Topics: Clobetasol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Humans; Nicotinic Acids; Pilot Projects; Psoriasis; Quality of Life; Scalp; Severity of Illness Index; Skin Cream; Treatment Outcome | 2021 |